Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Gastroenterology|May 19, 2009
Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanismSripathi M Sureban, Randal May, Satish Ramalingam, et al.Medical Oncology (Northwood, London, England)|October 12, 2022
Morin inhibits colon cancer stem cells by inhibiting PUM1 expression in vitroRavi Gor, Linkon Saha, Sparsh Agarwal, et al.Colloids and Surfaces. B, Biointerfaces|June 23, 2022
Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticlesLizha Mary Lazer, Yasodha Kesavan, Ravi Gor, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|September 17, 2020
Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic ApproachSridhar Muthusami, Ilangovan Ramachandran, Sneha Krishnamoorthy, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|February 23, 2008
Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2Dharmalingam Subramaniam, Gopalan Natarajan, Satish Ramalingam, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|August 13, 2011
Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defectsZhiyun He, Dharmalingam Subramaniam, Satish Ramalingam, et al.Molecular Cancer Therapeutics|February 10, 2012
Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cellsSivapriya Ponnurangam, Joshua M V Mammen, Satish Ramalingam, et al.American Journal of Surgery|December 13, 2012
Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cellsGaurav Kaushik, Satish Ramalingam, Dharmalingam Subramaniam, et al.Current Gene Therapy|April 30, 2026
Genome Editing Technologies for Cancer TherapyGautham Chengizkhan, Arumugam Rajavelu, Sridhar Muthusami, et al.International Journal of Biological Macromolecules|October 17, 2017
Chitosan-based nano-formulation enhances the anticancer efficacy of hesperetinLizha Mary Lazer, Balaji Sadhasivam, Kanagaraj Palaniyandi, et al.Pageof 6